Anas, Maira A.

HRN: 24-02-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2023
AMPICILLIN 1GM (VIAL)
11/02/2023
11/08/2023
IVT
2gm
Now Then Q6
Thickly MSAF
Checking Final Appropriateness 

Indication:  ProphylaxisEmpirical De-escalation    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: